Pharmacy

Five questions for payers to ask when deciding coverage of genomic testsGenetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.
Potential CVS-Aetna merger: Top 6 industry implicationsHealthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.
Biosimilars can save billions of healthcare dollarsAnalysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.
Genetic testing in oncology: 5 things payers should knowAs genomics continues to evolve, here are five things to know about genetic testing and counseling.
Study: Formularies may be key to alleviating opioid epidemicNew Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
Five ways health executives can impact the opioid crisisConsider these five opportunities to help curb one of the biggest public health issues of the year.
Two opioid use disorder drug developments to watchNew physician-administered therapies on the horizon may help rein in the opioid epidemic.
Beta blockers not needed for heart attack survivors taking these drugsA new study has shocking results about beta blocker use in heart-attack survivors.
Top solutions to lower drug pricesPBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.
Oral specialty drug options on the horizon
Oral specialty drug options on the horizonAs more specialty drugs are approved, cost control strategies are key.